Poseida Therapeutics, Inc. — Form D

Poseida Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-12-24. The offering totals $36.0M, of which $23.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
Brent J WarnerExecutive OfficerSAN DIEGO, CA
Robert LyonsDirectorGrand Cayman, E9
Mark GergenDirectorSan Diego, CA
Mark GergenExecutive OfficerSan Diego, CA
Mark GergenRelated PersonSan Diego, CA
John SchmidRelated PersonSan Diego, CA
Sean MurphyRelated PersonSan Diego, CA
Charles M BaumDirectorBoston, MA
Harry J LeonhardtExecutive OfficerSan Diego, CA
Mark J GergenDirectorSan Diego, CA
Mark J GergenExecutive OfficerSan Diego, CA
Johanna M MyletExecutive OfficerSan Diego, CA
Luke M CorningDirectorSan Diego, CA
Cynthia M CollinsDirectorSan Diego, CA
Marcea B LloydDirectorSan Diego, CA
Kristin J YaremaExecutive OfficerSan Diego, CA
John B SchmidDirectorSan Diego, CA
Rafael J AmadoDirectorSan Diego, CA
David HirschDirectorSan Diego, CA
David HirschRelated PersonSan Diego, CA
John J SchmidDirectorSan Diego, CA
Noah J BerkowitzDirectorSan Diego, CA
Marcea Bland LloydDirectorSan Diego, CA
Marcea Bland LloydRelated PersonSan Diego, CA
Eric OstertagDirectorSan Diego, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2023-08-11D$25.0M$25.0M
2019-04-22D$150.0M$142.1M
2018-04-03D$30.5M$30.5M
2017-08-03D$15.0M$11.2M

More